Umbralisib in combination with ibrutinib in patients with relapsed or refractory chronic lymphocytic leukaemia or mantle cell lymphoma: a multicentre phase 1–1b study
2019 ◽
Vol 6
(1)
◽
pp. e38-e47
◽
Keyword(s):
Phase 1
◽
2017 ◽
Vol 182
(3)
◽
pp. 429-433
◽
Keyword(s):
Keyword(s):
2020 ◽
Vol 3
(3)
◽
pp. 27-31
Keyword(s):
2016 ◽
Vol 39
(3)
◽
pp. e70-e73
◽